How to select a best-value biological medicine? A practical model to support hospital pharmacists.

ABSTRACT:

Purpose

With the growing availability of biosimilars on the global market, clinicians and pharmacists have multiple off-patent biological products to choose from. Besides the competitiveness of the product's price, other criteria should be considered when selecting a best-value biological. This article aims to provide a model to facilitate transparent best-value biological selection in the off-patent biological medicines segment.

Summary

The presented model was developed on the basis of established multicriteria decision analysis tools for rational and transparent medicine selection, ie, the System of Objectified Judgement Analysis and InforMatrix. Criteria for the model were informed by earlier research, a literature search, and evaluation by the authors. The developed mode

SUBMITTER: Barbier L 

PROVIDER: S-EPMC9452170 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature